mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
Imatinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.02 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
GSK-650394 |
GDSC1000 |
pan-cancer |
AAC |
0.081 |
0.02 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
KIN001-236 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.02 |